Carisma Therapeutics, Inc.
Carisma Therapeutics, Inc. (CARM) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CARM · as of Jun 8, 2026
Key Statistics
Explore Carisma Therapeutics, Inc. Data
carm stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 33.3%
The CARM analyst consensus is Hold, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month price target is $6.00, representing +5999900.00% upside from the current price of $0.00.
Competitors & Peers
carm competitorsCARM
ASBP
CDT
ENVB
INDP
JSPRStock Performance
Full HistoryAbout Carisma Therapeutics, Inc.
Carisma Therapeutics, Inc. operates as a biopharmaceutical firm dedicated to pioneering chimeric antigen receptor (CAR) macrophage therapies specifically designed to target solid cancerous growths. It…
what is carisma therapeutics, inc. · carm stock overview · carisma therapeutics, inc. company profile · who is carisma therapeutics, inc. ceo · carm OTC · carisma therapeutics, inc. headquarters · carisma therapeutics, inc. business segments
About Stock Overview & Key Data
Carisma Therapeutics, Inc. (CARM) is a Healthcare company in the Biotechnology industry, listed on OTC since Feb 6, 2014. As of the latest trading session, CARM stock price is $0.00, with a market capitalization of $4,185. The stock has returned -99.96% over the past 12 months and -99.77% year-to-date.
According to 6 Wall Street analysts, the consensus rating for Carisma Therapeutics, Inc. stock is Hold, with an average 12-month price target of $6.00. In fiscal year 2024, Carisma Therapeutics, Inc. reported revenue of $19.6M and net income of -$60.5M. For detailed data — including Carisma Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Carisma Therapeutics, Inc. (CARM) stock price is $0.00. The stock is traded on OTC under the ticker symbol CARM. The 52-week range is $0.00 – $1.27.